Drug Profile
TG 100115
Alternative Names: TG100-115Latest Information Update: 17 Sep 2015
Price :
$50
*
At a glance
- Originator TargeGen
- Class Cardiovascular therapies; Phenols; Pteridines; Small molecules
- Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease; Myocardial infarction